ALX Oncology Holdings Inc. is a clinical-stage oncology company focused on developing therapies to treat patients with cancer. With a strong pipeline of novel antibody-based immunotherapies, ALX Oncology is poised to make a significant impact in the field of cancer treatment.
Notification